Global Veterinary Artificial Insemination Market: Overview
Multiple trends and drivers are helping the global veterinary insemination market chart growth over the forecast period of 2019 to 2027. One of these is demand growing from cattle rearers, who benefit immensely from better productivity and profitability of associated operations. Reasons why artificial insemination is preferred over natural mating is that it reduces risks, allows for easy transportation and storage for semen, and enables multiple females being impregnated at the same time as a single ejaculation, once diluted can impregnate about 100 females. By storing semen, it is pertinent to note that progeny from males can be produced even after they have passed their reproductive age.
Looking for exclusive market insights from business experts? Request a Custom Report here
Global Veterinary Artificial Insemination Market: Notable Development
Active measures taken by prominent players in the global veterinary artificial insemination market are leading to some notable developments in the vendor landscape in terms of level of competition, and how it would operate going forward. A glimpse is provided below:
2018: Genetic evaluation capabilities of Neogen were improved once it acquired Livestock Genetic Services. In the same year, Genus ABS’s sales increased by 25% after it launched Sexcel in 2017. This is set to increase competition in the market.
Renowned and proactive names in the fragmented vendor landscape of global veterinary artificial insemination market are the following:
- Jorgensen Labs
- Merck Animal Health
- PBS Animal Health
- Revival Animal Health
- Santa Cruz Biotechnology, Inc.
- Swine Genetics
- IMV Technologies
- Zoetis
- Neogen Corporation
- Bovine Elite LLC
- Agtech Inc.
Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report
Global Veterinary Artificial Insemination Market: Key Trends and Drivers
In the upcoming market report, prepared by Transparency Market Research, a number of prominent trends and drivers, contributing significantly to growth in the market, are detailed out. An overview of some of these growth factors is provided below:
- Focused breeding animal selection is one of the most significant benefits of the veterinary artificial insemination. As rearers seek stronger next generation, demand for artificial insemination grows. This is also being supported by growth in semen sexing technology. This is extensively used in dairy herds. Market players are coming up with better products in this market, driving up demand for both technology as well as focused breeding.
- Factors such as growing awareness regarding benefits of reduction of disease transmission are contributing to growth in the global veterinary artificial insemination market over the forecast period. This method is also quite in sync with the new-age needs of farmers and animal rearers who are also opting for artificial insemination because of the better hygiene factor.
Pre Book Veterinary Artificial Insemination Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=73420<ype=S
Global Veterinary Artificial Insemination Market: Regional Analysis
Asia Pacific (APAC) is will be a lucrative market over the forecast period owing to a large cattle population marking the regional landscape. It is pertinent to note here that in APAC, India and China will be massive contributors to growth. Brazil will be another country in the global market which will chart notable growth and present players with untapped growth opportunities. It will capitalize upon effectively having used Artificial Insemination in the past. And, as per BAAI – Brazilian Association of Artificial Insemination – commercialized dozes are increasing in number. In 2017, 14 million semen dozes were notes. It is a steep rise from 7 million in 2003. FTAI (Fixed Time Artificial Insemination) technique is also being deployed in this market. It is pertinent to note here that Europe is witnessing increase in adoption of this method.
